The fact that the impact of GPx-1 deficiency on macrophage proliferation could be abolished by the GPx mimic ebselen (Figs. 3 A, 5 A) opens novel avenues of therapeutic strategies against atherosclerosis. Here, GPX1 is linked to atherosclerosis.